Lanier Biotherapeutics Revenue

Biotechnology Research • Athens, Georgia, United States • 1-10 Employees

Lanier Biotherapeutics revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	No funding

Key Contact at Lanier Biotherapeutics

Daniel White

Co-Founder, President and CEO

Company overview

Headquarters	150 Ben Burton Rd, Bogart, Georgia 30622, US
Website	lanierbio.com
NAICS	541714
Employees	1-10

About Lanier Biotherapeutics

Lanier Biotherapeutics was founded by combining the businesses of Biophtha and Abeome, to further develop an existing first-in-class biologics portfolio for specialty disease, with the ultimate goal of improving the way we survive, age, and live. Lanier targets four major verticals: Multi-functional Retina, Type 2 Inflammation, Dermatology, and ImmunoOncology. Lanier’s lead developments programs include LNR 653.1, a fully humanized anti-VEGF / IL-17A multifunctional antibody for the treatment of retinal neovascularization diseases and LNR 125.36, a fully humanized anti-IL-25 monoclonal antibody for the treatment of Type 2 Inflammatory diseases.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Lanier Biotherapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Lanier Biotherapeutics has never raised funding before.

Lanier Biotherapeutics Tech Stack

Discover the technologies and tools that power Lanier Biotherapeutics's digital infrastructure, from frameworks to analytics platforms.

Animate.css

UI frameworks

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

HSTS

Security

PHP

Programming languages

WordPress

Blogs

Yoast SEO

SEO

GoDaddy

Hosting

Slider Revolution

Photo galleries

Frequently asked questions

Lanier Biotherapeutics is located in Athens, Georgia, US.

Lanier Biotherapeutics generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.

Lanier Biotherapeutics has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Lanier Biotherapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Lanier Biotherapeutics

Daniel White

Co-Founder, President and CEO

4.8

40,000 users